Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 9Withdrawn 3Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 9INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1Breast 1

Conditions

Pain 1Neoplasm Metastasis 1Colorectal Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Paclitaxel 31Cyclophosphamide 30Cisplatin 29Bevacizumab 28Carboplatin 27Fluorouracil 24pembrolizumab 21Nivolumab 21Leucovorin 20Rituximab 19avelumab 18Gemcitabine 18Docetaxel 18Dexamethasone 18Capecitabine 17ALT-803 15130-nm albumin-bound paclitaxel 14Oxaliplatin 12Cetuximab 12fludarabine 11Ipilimumab 11venetoclax 10atezolizumab 10Radiosurgery 10Radiotherapy 9Pemetrexed 9Omacor 9Lenalidomide 9Bendamustine Hydrochloride 9yeast-CEA vaccine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × INDUSTRY × Cryosurgery × Clear all
NCT01461252 2021-07-16

Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases

Boston Scientific Corporation

Phase 1 Withdrawn
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT01741038 2020-01-22

AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer

Mirror Biologics, Inc.

Phase 2/3 Withdrawn
Gastrointestinal

Colorectal Neoplasms

NCT02018419 2020-01-22

MBC

Mirror Biologics, Inc.

Phase 1/2 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡